Drug discovery > Pre-Clinical Development Products & Reviews

Single bacterial cell detection - Rapid quantification - No culturing required - Data report generation

The LUNA-II™ Automated Cell Counter uses precision brightfield optics, an autofocusing liquid lens, sophisticated image analysis software, and an onboard computer to provide a truly automated solution for brightfield cell counting.

The LUNA-STEM™ takes adipose-derived stem cell and SVF samples to count live nucleated cells, dead nucleated cells, and non-nucleated cells with precision and consistency for downstream procedures.

Yeast strains used in food and drink production can be notoriously clumpy.  The LUNA-II YF™ has an autofocusing cell counting and declustering algorithm that counts individual yeast cells in just 15 seconds.

Accurate cell counts in as little as 7 seconds: Fast, accurate, and affordable automated cell counters from Logos Biosystems.

The LUNA-FX7™ is our most powerful cell counter to date, with unmatched cell counting accuracy, new 1, 3 and 8-chamber slide options, state of the art optics, dual fluorescent and brightfield detection, and precision autofocus. The LUNA-FX7™’s new features such as the Bioprocess mode, Quality Control mode, and the CountWire™ (21 CFR Part 11 compliant) software will help companies and facilities meet and surpass quality and re…

The QUANTOM™ Total Cell Staining Kit is used to label bacterial cells for counting with the QUANTOM Tx™ Microbial Cell Counter.

The disposable LUNA™ Cell Counting Slides offer the ultimate counting experience. 

PhysioMimix™ microphysiological systems generate in vitro microtissues that mimic the structure and function of human tissues and organs. Through the simulation of human biological conditions, they bridge the gap between traditional cell culture and human studies, reliably predicting drug effects to facilitate the accelerated development of safe and efficacious therapeutics. 

The ApoTox-Glo™ Triplex Assay combines three assay chemistries to easily assess viability, cytotoxicity and apoptosis events in the same cell-based assay well. First, viability and cytotoxicity are determined by measuring two differential protease biomarkers simultaneously with the addition of a single nonlytic reagent containing two peptide substrates. The live-cell protease activity is restricted to intact viable cells and i…